Development and validation of a bioanalytical assay for the measurement of total and unbound teicoplanin in human serum

BACKGROUND: The glycopeptide teicoplanin is considered first-line treatment for severe infections caused by Gram-positive bacteria. Individualized treatment of teicoplanin is gaining interest. As only protein-unbound drug is pharmacologically active, a sensitive assay measuring unbound and total tei...

Descripción completa

Detalles Bibliográficos
Autores principales: Mouton, J W A, Raaijmakers, J, Botterblom, M, Toonen, M, ter Heine, R, Smeets, R L, Brüggemann, R J M, te Brake, L, Jager, N G L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631822/
https://www.ncbi.nlm.nih.gov/pubmed/37757461
http://dx.doi.org/10.1093/jac/dkad290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631822/
https://www.ncbi.nlm.nih.gov/pubmed/37757461
http://dx.doi.org/10.1093/jac/dkad290

Ejemplares similares